ONCOLOGIST-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-04-28 ms2000001677941076 来自福建省

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：甲状腺;内分泌
经验分享：兄弟们别投，小修被拒了
2.1 投稿
2.7 under review
2.20 With Editors
3.1 minor revision
3.17 revised manuscript submitted返修修回
3.22 Under Review
3.31 With Editors
4.20 With Editor
4.21 Reject

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-01-02 123b9b72m07暂无昵称

请问有没有under review半年的，发邮件也不回复

193 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-03-08 阿曾曾曾曾来自上海

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-07-30 doctor0805

审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0
偏重的研究方向：临床
经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。
另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！

224 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-01-08 1473c9c6m76暂无昵称来自上海

审稿速度:6.0
经验分享：已经3个月了，还没有出结果，哭

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2017-12-17 崔4009df17

11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？

242 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-03-16 1e1db0a2m84(暂无匿称)

有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的

322 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-12-17 ruicosta111

返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！

215 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-03-09 Kobe Byrant

一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表::
听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表:
听说这个杂志也是水刊？大家有什么看法？

sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？

187 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128980, encodeId=930a2128980e1, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：甲状腺;内分泌 经验分享：兄弟们别投，小修被拒了 2.1 投稿 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted返修修回 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:01:25 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=565067, encodeId=7c7b56506ec0, content=请问有没有under review半年的，发邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6d72431749, createdName=123b9b72m07暂无昵称, createdTime=Wed Jan 02 00:00:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118240, encodeId=a015211824055, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我2023.01.21交的小修，至今仍submitted状态，未至editor手上，催稿说编辑在旅游！！是不是在骗我啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Wed Mar 08 09:12:34 CST 2023, time=2023-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=805176, encodeId=04c98051e6a9, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:90.0 | 版面费用:1500.0 偏重的研究方向：临床 经验分享：第一次投稿，写了文章后先是吹牛投了JCO，被拒后偷偷注册了老板的邮箱，开始四处投稿，投的都是自己知道的，比如BMC cancer， breast cancer等，都被拒了。BMC被拒有点伤心，因为那个是3分左右的文章，后面就不知道怎么办了，也不想投了（每次投完都没改过），然后就看到这个杂志，本着随便投投，免得被老板问怎么样的心态，3月份投稿，结果4月份返修，major revision，特别激动！那时候还搜了搜major 被拒的可能性，网友说还是会被拒的，迅速改完后，4月31返回，一周后minor revision，认真改了后一周内返回。结果就是6月份录用，真是激动。 另外要说的就是审稿费，因为当时奔着随便投的去的，而且也没指望录用，当时投JCO的时候也交了，然后就被拒了，更何况这个也不报销，当时让我缴费的时候，正好英文老师教我们如何写cover letter，其中一个章节就是如何和杂志说你很穷，来自发展中国家等，于是我就把那个抄过去了，说我是个学生，来自发展中的国家，经费有限，还不给报销之类的，结果就是真没要我的版面费，哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu Jul 30 11:47:25 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109425, encodeId=a2d621094256a, content=审稿速度:6.0 经验分享：已经3个月了，还没有出结果，哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=1473c9c6m76暂无昵称, createdTime=Sun Jan 08 20:25:47 CST 2023, time=2023-01-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=550071, encodeId=8e575500e13c, content=11-13投的稿，到现在还是Manuscript Received by Editorial Office，一个星期前给编辑发了催稿信也没有回复。大家有遇到同样情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYNS2mEL7Ed2E1sbpOibOicvgW4eIicS1Th272yp1CJh3xVeH9dmjuCAFMgm77acTZgxI5af87vibE3Q/132, createdBy=fdc51702765, createdName=崔4009df17, createdTime=Sun Dec 17 09:44:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568176, encodeId=0f175681e65e, content=有没有投稿 5个月，发邮件不回，要去撤稿，也不理会的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7f2f58e7cd39af3548e526ce03d288e5/35d99bd608116038c280e861823db7ef.jpg, createdBy=cc822005876, createdName=1e1db0a2m84(暂无匿称), createdTime=Sat Mar 16 10:04:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581660, encodeId=caab581660d1, content=返修过去3个月，没有任何消息，写信也不回，不清楚是怎么回事！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yk3Ok9Palo9XeaUCxlW1rGtX62ibXjvyib7amSbLbQNXFYEC7XcYx4BZicEv2VlIjph17ThxMgBgIGLyaEQNceRYQ/132, createdBy=a7942020383, createdName=ruicosta111, createdTime=Tue Dec 17 00:00:00 CST 2019, time=2019-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567854, encodeId=0e7b56e854e7, content=一半的article都是II和III期临床试验，一篇修回的文章刚刚被拒，难度很大；另外一篇刚刚修回；你可以尝试中一篇，在谈是不是水刊sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？sunliang 2019-03-02 00:00:00 发表: 听说这个杂志也是水刊？大家有什么看法？, beContent=sunliang 2019-03-02 发表:: 听说这个杂志也是水刊？大家有什么看法？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Sat Mar 09 00:00:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099262, encodeId=2dd5109926200, content=误差线怎么计算？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

误差线怎么计算？

59 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务